ARM Holdings PLC: RBC Increases Target Price from $130 to $175
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 8 hours ago
0mins
Should l Buy ARM?
Source: moomoo
Company Announcement: ARM Holdings PLC has announced a new target price set by RBC.
Target Price Increase: The target price has been raised from $130 to $175.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ARM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ARM
Wall Street analysts forecast ARM stock price to rise
24 Analyst Rating
19 Buy
4 Hold
1 Sell
Strong Buy
Current: 134.960
Low
120.00
Averages
160.58
High
201.00
Current: 134.960
Low
120.00
Averages
160.58
High
201.00
About ARM
Arm Holdings plc is engaged in operating a global computing platform. It architects, develops, and licenses high-performance and energy-efficient Arm compute platforms. The Company’s principal operations and activities are the licensing, marketing, research and development of central processing unit (CPU) design intellectual property (IP), graphics processors, system IP, market optimized platform IP, and associated software, tools and other related services. Its complementary products include GPU and NPU accelerators, interconnect, and others. Its primary product offerings are CPU products that address diverse performance, power, and cost requirements. It offers a family of GPU and NPU products providing efficient computing acceleration and an optimal visual experience across a wide range of devices. Its CPU, GPU, and System IP products integrated into a foundational compute platform optimized for a specific end market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Arm Launches First Data Center CPU to Support AI Infrastructure
- First Data Center CPU Launch: Arm introduces the Arm AGI CPU, its first data center CPU designed for AI, delivering over 2x performance compared to x86 platforms, marking the company's entry into production silicon products and expected to accelerate AI infrastructure development.
- Partner Support: Developed in collaboration with leading partners like Meta, the Arm AGI CPU is backed by strong support from the global ecosystem, anticipating over 4x growth in CPU demand for data centers to meet the rising AI workload.
- Performance and Scalability: The Arm AGI CPU supports up to 136 Arm Neoverse V3 cores per CPU with a 300-watt TDP, providing deterministic performance under sustained loads, significantly enhancing workload density and computational efficiency in data centers.
- Ecosystem Expansion: Supported by over 50 leading companies, including AWS, Google, and NVIDIA, the launch of the Arm AGI CPU solidifies Arm's strategic position in AI infrastructure, driving future technological innovations.
See More
ON Holding Leadership Shakeup Amid Growth Slowdown
- Leadership Change: ON Holding has appointed co-founders David Allemann and Caspar Coppetti as co-CEOs effective May 1, aiming to address disappointing sales forecasts that led to a stock price drop, with market concerns about whether this founder-led transition can maintain the innovative edge.
- Executive Overhaul: The leadership shakeup extends beyond the CEO role, with a new CFO and COO also set to take over in May as part of a comprehensive operational reset, intended to enhance management efficiency and market competitiveness.
- Premium Market Strategy: The new co-CEOs are focusing on selective high-margin product franchises, aiming to maintain the brand's
See More
Market Update: Oil Prices Slide Amid Tech Stock Performance
- Oil Price Impact: Oil prices have dropped below $90 per barrel due to hopes for a truce between the U.S. and Iran, which could positively influence the stock market, as falling oil prices generally lead to a more favorable outlook for equities despite Iran's denial of ceasefire intentions.
- Surge in Arm Chip Demand: Arm's first in-house designed AGI CPU chip has seen incredible demand, with projections of $15 billion in revenue by 2031, prompting Raymond James to upgrade its stock rating from hold to buy, resulting in a 12% increase in share price, aligning with Nvidia's GPU performance.
- OpenAI Fundraising Milestone: OpenAI has raised an additional $10 billion from investors, bringing its total fundraising in this round to over $120 billion, with significant participation from institutions like Microsoft, indicating strong market confidence in its future growth potential.
- Merck's Strategic Acquisition: Merck is acquiring cancer biotech Terns Pharmaceuticals for $6.7 billion to bolster its oncology portfolio ahead of the 2028 patent expiration of its top-selling drug Keytruda, highlighting Merck's strategic focus on cancer treatment advancements.
See More
Arm Launches Data Center CPUs, Shares Rise 12%
- New Product Launch: Arm Holdings has introduced its AGI CPU focused on data centers, projecting annual revenue of $25 billion by 2031, which represents over sixfold growth from 2025, indicating strong market potential and long-term profitability.
- Market Share Growth: Arm aims to capture approximately 15% of the $100 billion total addressable market for server CPUs, with revenue expectations of $1 billion in fiscal years 2027 and 2028, showcasing its competitiveness in the rapidly growing AI computing sector.
- Technical Advantages: The new CPU features 136 cores, offering 6 GB/s memory bandwidth per core with a power consumption of around 300 watts, catering to clients like Meta and OpenAI seeking low-power computing solutions, thereby solidifying Arm's position in efficient computing.
- Positive Industry Response: Analysts are generally optimistic about Arm's strategic shift, believing that its AGI CPU will become the best choice for AI workloads, with expectations of rapid adoption by hyperscalers, driving continued stock price appreciation.
See More
Latest Rating Changes on Wall Street
- Tesla Neutral Rating: Goldman Sachs maintains a neutral stance on Tesla, expressing caution regarding its semiconductor ventures, noting a mixed track record in semiconductor engineering, while suggesting potential applications for inference chips in data centers and distributed computing remain to be seen.
- Upgrade Based on Iran War: Wells Fargo upgrades Kinetik, ONEOK, and Enterprise Products Partners from equal weight to overweight, anticipating that the Iran war will create a structural shift in global energy markets, boosting demand for U.S. energy, particularly in Permian gas and NGL supply.
- ESCO Technologies Buy Initiation: Deutsche Bank initiates coverage on ESCO Technologies with a Buy rating and a $350 target price, highlighting its potential for “defensive growth at a discount” in the aerospace and defense sectors, indicating strong confidence in the company's future.
- Arm Rating Upgrade: Wolfe upgrades Arm from market perform to outperform, citing the company's recent in-house chip launch and significantly increased earnings forecasts for FY28 and FY31, setting a target price of $166, reflecting optimism about its new business model.
See More
Significant Premarket Moves in U.S. Stocks
- Fertilizer Price Fluctuation: CF Industries' shares fell nearly 4% as reports indicated that negotiations surrounding the U.S.-Iran war could signal an end to commodity shortages, despite a 27% increase since the conflict began.
- Chip Innovation: Arm's stock rose 13% after unveiling its first in-house chip, projecting $15 billion in revenue by 2031, highlighting its strong growth potential in the semiconductor market.
- Acquisition Deal: Terns Pharmaceuticals saw shares gain over 5% after Merck agreed to acquire the biopharma company for $53 per share in cash, valuing the deal at $6.7 billion, expected to close in Q2.
- Stock Buyback Plan: Robinhood's stock jumped 4% after announcing a $1.5 billion stock buyback plan, set to be executed over three years, aimed at enhancing shareholder value.
See More
Arm Launches First Data Center CPU to Support AI Infrastructure
- First Data Center CPU Launch: Arm introduces the Arm AGI CPU, its first data center CPU designed for AI, delivering over 2x performance compared to x86 platforms, marking the company's entry into production silicon products and expected to accelerate AI infrastructure development.
- Partner Support: Developed in collaboration with leading partners like Meta, the Arm AGI CPU is backed by strong support from the global ecosystem, anticipating over 4x growth in CPU demand for data centers to meet the rising AI workload.
- Performance and Scalability: The Arm AGI CPU supports up to 136 Arm Neoverse V3 cores per CPU with a 300-watt TDP, providing deterministic performance under sustained loads, significantly enhancing workload density and computational efficiency in data centers.
- Ecosystem Expansion: Supported by over 50 leading companies, including AWS, Google, and NVIDIA, the launch of the Arm AGI CPU solidifies Arm's strategic position in AI infrastructure, driving future technological innovations.
See More
ON Holding Leadership Shakeup Amid Growth Slowdown
- Leadership Change: ON Holding has appointed co-founders David Allemann and Caspar Coppetti as co-CEOs effective May 1, aiming to address disappointing sales forecasts that led to a stock price drop, with market concerns about whether this founder-led transition can maintain the innovative edge.
- Executive Overhaul: The leadership shakeup extends beyond the CEO role, with a new CFO and COO also set to take over in May as part of a comprehensive operational reset, intended to enhance management efficiency and market competitiveness.
- Premium Market Strategy: The new co-CEOs are focusing on selective high-margin product franchises, aiming to maintain the brand's
See More
Market Update: Oil Prices Slide Amid Tech Stock Performance
- Oil Price Impact: Oil prices have dropped below $90 per barrel due to hopes for a truce between the U.S. and Iran, which could positively influence the stock market, as falling oil prices generally lead to a more favorable outlook for equities despite Iran's denial of ceasefire intentions.
- Surge in Arm Chip Demand: Arm's first in-house designed AGI CPU chip has seen incredible demand, with projections of $15 billion in revenue by 2031, prompting Raymond James to upgrade its stock rating from hold to buy, resulting in a 12% increase in share price, aligning with Nvidia's GPU performance.
- OpenAI Fundraising Milestone: OpenAI has raised an additional $10 billion from investors, bringing its total fundraising in this round to over $120 billion, with significant participation from institutions like Microsoft, indicating strong market confidence in its future growth potential.
- Merck's Strategic Acquisition: Merck is acquiring cancer biotech Terns Pharmaceuticals for $6.7 billion to bolster its oncology portfolio ahead of the 2028 patent expiration of its top-selling drug Keytruda, highlighting Merck's strategic focus on cancer treatment advancements.
See More
Arm Launches Data Center CPUs, Shares Rise 12%
- New Product Launch: Arm Holdings has introduced its AGI CPU focused on data centers, projecting annual revenue of $25 billion by 2031, which represents over sixfold growth from 2025, indicating strong market potential and long-term profitability.
- Market Share Growth: Arm aims to capture approximately 15% of the $100 billion total addressable market for server CPUs, with revenue expectations of $1 billion in fiscal years 2027 and 2028, showcasing its competitiveness in the rapidly growing AI computing sector.
- Technical Advantages: The new CPU features 136 cores, offering 6 GB/s memory bandwidth per core with a power consumption of around 300 watts, catering to clients like Meta and OpenAI seeking low-power computing solutions, thereby solidifying Arm's position in efficient computing.
- Positive Industry Response: Analysts are generally optimistic about Arm's strategic shift, believing that its AGI CPU will become the best choice for AI workloads, with expectations of rapid adoption by hyperscalers, driving continued stock price appreciation.
See More
Latest Rating Changes on Wall Street
- Tesla Neutral Rating: Goldman Sachs maintains a neutral stance on Tesla, expressing caution regarding its semiconductor ventures, noting a mixed track record in semiconductor engineering, while suggesting potential applications for inference chips in data centers and distributed computing remain to be seen.
- Upgrade Based on Iran War: Wells Fargo upgrades Kinetik, ONEOK, and Enterprise Products Partners from equal weight to overweight, anticipating that the Iran war will create a structural shift in global energy markets, boosting demand for U.S. energy, particularly in Permian gas and NGL supply.
- ESCO Technologies Buy Initiation: Deutsche Bank initiates coverage on ESCO Technologies with a Buy rating and a $350 target price, highlighting its potential for “defensive growth at a discount” in the aerospace and defense sectors, indicating strong confidence in the company's future.
- Arm Rating Upgrade: Wolfe upgrades Arm from market perform to outperform, citing the company's recent in-house chip launch and significantly increased earnings forecasts for FY28 and FY31, setting a target price of $166, reflecting optimism about its new business model.
See More
Significant Premarket Moves in U.S. Stocks
- Fertilizer Price Fluctuation: CF Industries' shares fell nearly 4% as reports indicated that negotiations surrounding the U.S.-Iran war could signal an end to commodity shortages, despite a 27% increase since the conflict began.
- Chip Innovation: Arm's stock rose 13% after unveiling its first in-house chip, projecting $15 billion in revenue by 2031, highlighting its strong growth potential in the semiconductor market.
- Acquisition Deal: Terns Pharmaceuticals saw shares gain over 5% after Merck agreed to acquire the biopharma company for $53 per share in cash, valuing the deal at $6.7 billion, expected to close in Q2.
- Stock Buyback Plan: Robinhood's stock jumped 4% after announcing a $1.5 billion stock buyback plan, set to be executed over three years, aimed at enhancing shareholder value.
See More
